Researchers uncover mechanism of protein GBP1 in immune defense

The protein GBP1 is a vital component of our body’s natural defence against pathogens. This substance fights against bacteria and parasites by enveloping them in a protein coat, but how the substance manages to do this has remained unknown until now.

Not Disclosed Neurodegeneration by Eli Lilly and Co for Neurodegenerative Diseases: Likelihood of Approval

Not Disclosed Neurodegeneration is under clinical development by Eli Lilly and Co and currently in Phase I for Neurodegenerative Diseases.

February 20, 2024

Q&A with CDC Director Mandy Cohen: On communication, trust, and getting things done

The new director of the Centers for Disease Control and Prevention, Mandy Cohen, is only two weeks into her new job. But already she hears

July 26, 2023

Researchers receive £2.4 million to generate evidence on the new NHS Pharmacy First service

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2.4m by the National Institute for Health and Care Research (NIHR)

February 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.